Drs Nunnery and Premji discuss key breast cancer data presented at the 2026 ESMO Congress.
Sarah Premji, MD
Advertisement
Sarah Premji, MD, is a breast medical oncologist at Sarah Cannon Research Institute Oncology Partners and the assistant director of breast cancer research at Sarah Cannon Research Institute
Articles by Sarah Premji, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Pimicotinib for Symptomatic TGCT
2
Dr Backes on BEHOLD-1 Data With Mocertatug Rezetecan in Platinum-Resistant Ovarian Cancer
3
Dr Patel on How Zidesamtinib Data From ARROS-1 Compare With Taletrectinib Data From TRUST-I/TRUST-II in ROS1-Positive NSCLC
4
Longer Follow-Up of BEHOLD-1 Shows Durable Responses With Mo-Rez in Platinum-Resistant Ovarian Cancer
5